Health
Portugal Limits Prescriptions for Popular Diabetes and Weight Loss Drugs Amid Misuse Concerns
The Portuguese government has moved to curb the misuse of certain high-demand diabetes and weight loss drugs, as well as glucose monitoring devices, by restricting which doctors can prescribe them.
Effective Friday, only specialists in endocrinology and nutrition, internal medicine, paediatrics, and general and family medicine will be authorised to prescribe glucagon-like peptide-1 (GLP-1) receptor agonists — including Ozempic, Wegovy, and Mounjaro — and glucose sensors. These injectable medications, used to treat type 2 diabetes and obesity, have gained worldwide popularity for their weight loss effects, creating shortages and driving demand beyond approved medical use.
Ozempic, produced by Danish pharmaceutical firm Novo Nordisk, is officially authorised in Portugal solely for treating type 2 diabetes. However, its appetite-suppressing effects have made it a sought-after weight loss aid, leading to market shortages. Wegovy, also from Novo Nordisk, and Eli Lilly’s Mounjaro are approved for both diabetes and obesity treatment. According to official data, Portuguese consumers spent approximately €21 million on these drugs in the first four months of 2025 alone.
Glucose sensors, designed to help diabetics monitor blood sugar levels, have also been in short supply. Reports indicate they have been prescribed by non-specialist doctors and are being used by dieters, athletes, social media influencers, and even for monitoring animals.
The Ministry of Health, which announced the regulation in April, cited “recent reports of improper access to and use of these technologies, which have jeopardised their availability to those who actually need them.” It said the measure is intended to “regulate and correct these distortions, promoting effective and adequate access to these essential health tools.”
João Raposo, president of the Portuguese Society of Diabetology (SPD), welcomed the move but expressed doubt over its effectiveness, suggesting that prescriptions outside the approved specialties may already be limited. While not opposed to the drugs being used for obesity treatment, Raposo warned of “anomalous prescriptions and a lack of monitoring” among non-diabetic users.
“Health cannot be subject to the laws of the market,” he stressed, noting the temptation such drugs pose for those “desperately looking for solutions.”
GLP-1 medicines are reimbursed by the Portuguese state at 90 per cent, while glucose sensors can be subsidised up to 85 per cent. However, shortages have also fuelled a black market, raising concerns about counterfeit products.
The government hopes the new prescribing rules will ensure that supplies remain available for patients who medically require them — but experts caution that enforcement and oversight will be key to its success.
Health
Global Mental Health Cases Near 1.2 Billion as Anxiety and Depression Drive Sharp Worldwide Rise
A major global analysis has found that mental health conditions have surged to an estimated 1.2 billion people worldwide, driven largely by steep increases in anxiety and depression over the past three decades.
The findings, published in The Lancet as part of the Global Burden of Disease Study 2023, show that the number of people living with mental disorders has almost doubled since 1990, marking a 95% rise. Researchers say major depressive disorder and anxiety disorders have seen even sharper growth, increasing by 131% and 158% respectively, making them the most prevalent mental health conditions globally.
The report describes mental illnesses as widespread conditions that create long-term disability and significant human suffering. It also highlights broader consequences for economies and public services, including reduced productivity, lower workforce participation and increasing pressure on health and welfare systems.
Researchers estimate that in 2023 alone, around 620 million females and 552 million males were affected by mental health conditions. While the overall burden is rising across both sexes, the study points to notable differences in the types and prevalence of disorders.
Among women, depression and anxiety were the most commonly reported conditions, alongside higher rates of eating disorders such as anorexia nervosa and bulimia nervosa. The report links this disparity to a mix of biological, social and structural factors, including exposure to domestic violence, sexual abuse, gender inequality and reproductive health-related changes.
In contrast, neurodevelopmental and behavioural disorders, including attention deficit hyperactivity disorder (ADHD), conduct disorder and autism spectrum conditions, were more frequently diagnosed in men.
Teenagers aged 15 to 19 were identified as the group experiencing the highest mental health burden globally, raising concerns about early onset of conditions and insufficient preventive care for young people.
The study identifies several key risk factors associated with mental illness, including childhood sexual violence, bullying and intimate partner violence. These factors are strongly linked to conditions such as depression, schizophrenia, bipolar disorder and anxiety disorders. However, researchers note that such exposures have remained relatively stable over time and account for only a portion of the overall rise.
According to the authors, broader drivers are likely contributing to the increasing prevalence of mental disorders. These include genetic and biological influences, poverty, inequality, and the growing impact of global crises such as armed conflict, pandemics, natural disasters and climate-related stress.
While mental health conditions have long been a leading cause of disability worldwide, the report warns that the situation is worsening. At the same time, health systems have not expanded services at a pace matching demand.
The authors caution that the gap between rising need and limited access to care is becoming more pronounced, leaving millions without adequate treatment or support.
Health
Europe Records Sharp Rise in Sexually Transmitted Infections, ECDC Warns
Health
White House Rejects Report It Blocked Return of Ebola-Infected US Doctor
-
Entertainment2 years agoMeta Acquires Tilda Swinton VR Doc ‘Impulse: Playing With Reality’
-
Sports2 years agoChina’s Historic Olympic Victory Sparks National Pride Amid Controversy
-
Business2 years agoSaudi Arabia’s Model for Sustainable Aviation Practices
-
Business2 years agoRecent Developments in Small Business Taxes
-
Home Improvement1 year agoEffective Drain Cleaning: A Key to a Healthy Plumbing System
-
Politics2 years agoWho was Ebrahim Raisi and his status in Iranian Politics?
-
Sports2 years agoKeely Hodgkinson Wins Britain’s First Athletics Gold at Paris Olympics in 800m
-
Business2 years agoCarrectly: Revolutionizing Car Care in Chicago
